why choose us

First received: January 18, 2023

Clinical Trial: A Study to Assess the Safety and Pharmacokinetics of AD-104-A

Study Status: Completed

Recruit Status: RECRUITING

Condition: Hyperlipidemias

Study Type: INTERVENTIONAL


Official Title: A Parallel, Open-Label, Single-Dose Administration, Phase 1 Clinical Study to Assess the Safety and Pharmacokinetics of AD-104-A in Healthy Adult Volunteers and Patients With Renal Impairment

Brief Summary: Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-104-A

Read more